Piper Jaffray to Host 28th Annual Healthcare Conference

NEW YORK–(BUSINESS WIRE)– Piper
Jaffray Companies (NYSE: PJC), a leading investment bank and asset
management firm, will host its 28th annual Healthcare Conference in New
York on November 29-30, 2016.

The Piper Jaffray Healthcare Conference will showcase senior management
teams from nearly 300 leading public and private companies delivering
presentations to an audience of nearly 2,000, including institutional
investors, equity portfolio managers and research analysts. The two-day
event will also host more than 3,600 private one-on-one meetings with
company management. Presenting companies represent several healthcare
sectors, including: biotechnology, medical services, specialty
pharmaceuticals, medical technology, and life sciences tools and
diagnostics.

Highlighting the conference will be several panel discussions featuring
industry experts, physicians and academicians moderated by Piper Jaffray
healthcare senior research analysts:

• Underdiscovered Neuro-Innovators Panel
  Moderated by Charles
  Duncan, Ph.D.
• Political Panel
  Moderated by Matt
  O’Brien, Bill
  Quirk and Brooks
  West
• Oncolytic Virus Panel: Gene Therapy Meets Cancer Immunotherapy Panel
  Moderated
  by Josh
  Schimmer, M.D.
• Underdiscovered Platform-Enabled Drug Developers Panel
  Moderated
  by Charles
  Duncan, Ph.D.
• Gene Therapy: The NAV Masters Panel
  Moderated by Josh
  Schimmer, M.D.
• Genomics 3.0: The Third Wave of Gene Targeting Therapies is Coming
  Panel
  Moderated by Josh
  Schimmer, M.D.
• Healthcare Executive Panel
  Moderated by Matt
  O’Brien and Brooks
  West

“As a frontrunner in the healthcare industry, our goal at the conference
is to help investors navigate this evolving sector in the context of a
regulatory and market landscape that continues to shift,” said Michael
Cox, director of equity research at Piper Jaffray. “By bringing
together hundreds of leading healthcare companies, we are able to
provide our clients with a unique and exclusive experience.”

Follow the conversation using the event hashtag #PJCHCC16

Company and investor participation in the conference is by invitation
only. Clients interested in attending should contact their Piper Jaffray
representative. General and research-related media inquiries should be
directed to analystmediarelations@pjc.com.
All other media inquiries should be directed to Pamela Steensland at pamela.k.steensland@pjc.com.

Information as of November 14, 2016. Subject to change.

About Piper Jaffray
Piper Jaffray Companies (NYSE: PJC) is a
leading investment bank and asset management firm. Securities brokerage
and investment banking services are offered in the U.S. through Piper
Jaffray & Co., member SIPC and FINRA; in Europe through Piper Jaffray
Ltd. and Simmons & Company International Limited, authorized and
regulated by the U.K. Financial Conduct Authority; and in Hong Kong
through Piper Jaffray Hong Kong Limited, authorized and regulated by the
Securities and Futures Commission. Asset management products and
services are offered through five separate investment advisory
affiliates―U.S. Securities and Exchange Commission (SEC) registered
Advisory Research, Inc., Piper Jaffray Investment Management LLC, PJC
Capital Partners LLC and Piper Jaffray & Co.; and Guernsey-based
Parallel General Partners Limited, authorized and regulated by the
Guernsey Financial Services Commission.

© 2016 Piper Jaffray Companies. 800 Nicollet Mall, Suite 1000,
Minneapolis, Minnesota 55402-7036

Follow Piper Jaffray: LinkedIn
| Facebook
| Twitter

View source version on businesswire.com: http://www.businesswire.com/news/home/20161115006621/en/